Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH

NCT05569655 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension
Randomized Controlled Trial

Interventions

DRUG: Tolvaptan
DRUG: Furosemide

Sponsor

Chinese Pulmonary Vascular Disease Research Group